Cancer Metastasis Promotion versus Suppression of Prostate Anti-androgen Receptor ASC-J9® Lead to MDV3100/Enzalutamide versus Casodex/Bicalutamide or Therapies with Anti-androgens Differential Androgen Deprivation Molecular Bases of Disease: